Nerve Screening • An Integral Component of Urology & Gynecology Pathologies
Seamless Integration with KOSMD Consulting, Inc.
Seamless Integration with KOSMD Consulting, Inc.
Nerve Testing Leads to Diagnostic Accuracy & Care Efficiency
•Urologic • Gynecologic •Urogyn
The Physician generates income through better care
National Average Reimbursement $274.00
Quantification of the Bulbocavernosus Revflex Allows for Data Driven Treatment Improving Patient Outcomes
-
Screen
5’ Screening of the Bulbocavernosus Reflex identifies nerve abnormalities that contribute to the pathologies. This painless screening is recommended for evaluation of ? 71 ICD-10 codes.
-
Quantify
Pudendal Nerve pathology is indicated by a latency > 45 ms. Nerve abnormalities have been found to be bilateral or unilateral. The latency dictates the best treatment option for > 71 ICD-10 diagnoses.
-
Data Driven Treatment
The latency is the primary determinant of treatment. If delayed > 45 ms, but < 100 ms, the treatment plan is distinctly different than when the latency is > 100 ms. Knowledge is power. Understanding the latency eliminates the guess work, allowing patients to be treated correctly the first time around.
Fast & Easy to Implement
5 Minute Painless • In-Office Test
Screening is Reimbursable in Evaluation of > 71 IDC-10 Diagnoses
º Incontinence
º Overactive Bladder
º Pelvic Pain
º Erectile Dysfunction
º Prolapse
º Recurrent Urinary tract Infections
º Benign Prostatic Hypertrophy
º Prastatic Malignancies
º etc…
Screening During Pregnancy
Justifies Early Onset Pelvic Floor Rehab & Preservation of Nerve Function
º Documentation of Nerve Function Pre & Post Delivery
BCR Screening Pre & Post Surgery Reduces Liability
º Baseline Nerve Dysfunction Documented
º Provides Realistic Pre-operative Risk Assessment
º Knowing Pre-existing Risk Improves Communication with Patient Regarding Expected Outcome
º Allows for Faster Initiation of Treatment Post-operatively such as Pelvic Floor Rehab or E-stim
Screening Before • During • After Pelvic Floor Rehab
º Document Baseline
º Monitor Improvement
ºChange PVR Protocol According to Response
º Objective Data to Substantiate Extension of Treatment as Indicated
Get Started Now
To learn more or to start the process contact us right away.